Synonyms: BDTX 1535 | BDTX-1535 | BDTX1535 | Compound No. 37 [WO2021030711]
Compound class:
Synthetic organic
Comment: BDTX-1535 is a brain-penetrant EGFR inhibitor. The chemical structure is claimed in Black Diamond Therapeutics' patent WO2021030711A1 [1]. BDTX-1535 is proposed to mitigate tumour resistance to the EGFRT790M mutant selective inhibitor osimertinib [2], as it is active against a range of osimertinib-acquired and uncommon resistance variants, and amplified wild-type EGFR. Its efficacy againts EGFR exon 20 insertions is unreported. As it can cross the blood-brain barrier BDTX-1535 has potential to treat NSCLC metastases in the brain.
The chemical structure of BDTX-1535 is identical to that for the INN silevertinib (proposed list 132, Feb. 2025). ![]() Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
Classification ![]() |
|
Compound class | Synthetic organic |
IUPAC Name ![]() |
(E)-N-[4-(3-chloro-2-fluoroanilino)-7-[2-[(1R,5S)-3-methyl-3-azabicyclo[3.1.0]hexan-1-yl]ethynyl]quinazolin-6-yl]-4-morpholin-4-ylbut-2-enamide |
International Nonproprietary Names ![]() |
|
INN number | INN |
13382 | silevertinib |
Synonyms ![]() |
BDTX 1535 | BDTX-1535 | BDTX1535 | Compound No. 37 [WO2021030711] |
Database Links ![]() |
|
CAS Registry No. | 2607829-38-7 (source: WHO INN record) |
GtoPdb PubChem SID | 496703341 |
PubChem CID | 156071569 |
Search Google for chemical match using the InChIKey | LMOVDLRMIRLIJF-TUVXKDNKSA-N |
Search Google for chemicals with the same backbone | LMOVDLRMIRLIJF |
Search PubMed clinical trials | silevertinib |
Search PubMed titles | silevertinib |
Search PubMed titles/abstracts | silevertinib |
UniChem Compound Search for chemical match using the InChIKey | LMOVDLRMIRLIJF-TUVXKDNKSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | LMOVDLRMIRLIJF-TUVXKDNKSA-N |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖
BDTX-1535 (links to external site)
Cat. No. HY-153268 |